15 states sue Trump administration over changes to U.S. vaccine schedule
Source: SeekingAlpha
2026-02-25 07:19:21 ET
More on Pfizer, Merck, etc.
- Merck: Why Investors Should Remain Bullish Despite Patent Risks
- Pfizer: A Risky 6.3% Yield For Income-Oriented Investors
- Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades)
- GSK to acquire Canada's 35Pharma for $950M in cash
- Merck shares advanced for seven consecutive sessions
Read the full article on Seeking Alpha
For further details see:
15 states sue Trump administration over changes to U.S. vaccine schedule
Sanofi
NASDAQ: SNYNF
SNYNF Trading
-4.91% G/L:
$88.50 Last:
727 Volume:
$90.68 Open:
SNYNF Latest News
March 05, 2026 03:16:37 am
Press Release: Sanofi's Board of Directors proposes the appointment of Christel Heydemann as an independent director
March 04, 2026 12:30:40 pm
Press Release: Filing of an amendment to the French "Document d'Enregistrement Universel" containing the Annual Financial Report
March 02, 2026 01:00:00 am
Press Release: Sanofi's rilzabrutinib earns orphan drug designation in Japan for IgG4-related disease
SNYNF Stock Data
$121,583,170,304
1,228,540,835
N/A
1460
N/A
Pharmaceuticals
Healthcare
FR
Paris
